Document ID: chunk:federal_register_of_legislation:F2025L00049:schedule:8:p1
Version: federal_register_of_legislation:F2025L00049
Segment Type: schedule
Provision Reference: sch 8 (pt 1/2)
Character Range: 430261–433870

Schedule 8—Controlled drugs

Note 1: See paragraph 7(b), sections 16, 17, 28, 31, 50 and subsection 57(1).
Note 2: Substances marked # are listed in Appendix D.
ACETYLDIHYDROCODEINE.
ACETYLMETHADOL.
ACETYLMORPHINES.
ALFENTANIL.
ALPHACETYLMETHADOL.
ALPHAPRODINE.
# ALPRAZOLAM.
AMFETAMINE.
AMOBARBITAL except when included in Schedule 4.
ANILERIDINE.
BENZYLMORPHINE.
BEZITRAMIDE.
BUPRENORPHINE.
BUTOBARBITAL.
BUTORPHANOL.
# CANNABIS (including seeds, extracts, resins and the plant, and any part of the plant) when prepared or packed for human therapeutic use, when:

       (a) cultivated or produced, or in products manufactured[1], in accordance with the Narcotic Drugs Act 1967; and/or

       (b) for use in products manufactured in accordance with the Narcotic Drugs Act 1967; and/or

       (c) imported as therapeutic goods, or for use in therapeutic goods, for supply, in accordance with the Act; and/or

       (d) in therapeutic goods supplied in accordance with the Act;

     except:

       (e) when it is in a product to which item 4, 8, 10, 11 or 12 of Schedule 5A to the Therapeutic Goods Regulations 1990 applies; or

       (f) when separately specified in the NABIXIMOLS entry in this Schedule; or

       (g) when captured by the CANNABIDIOL entry in Schedule 4 or Schedule 3; or

       (h) hemp seed oil containing 75 mg/kg or less of cannabidiol and 10 mg/kg or less of tetrahydrocannabinols.
CARFENTANYL.
COCAINE.
CODEINE except when included in Schedule 4.
CODEINE‑N‑OXIDE.
CONCENTRATE OF POPPY STRAW (the material arising when poppy straw has entered into a process for concentration of its alkaloids).
4‑CYANO‑1‑METHYL‑4‑PHENYLPIPERIDINE (Pethidine intermediate A).
CYCLOBARBITAL.
DEXAMFETAMINE.
DEXTROMORAMIDE.
# DEXTROPROPOXYPHENE except when included in Schedule 4.
DIFENOXIN except when included in Schedule 4.
DIHYDROCODEINE except when included in Schedule 3 or 4.
DIHYDROMORPHINE.
# N, α ‑DIMETHYL‑3,4‑(METHYLENEDIOXY)PHENYLETHYLAMINE *(MDMA) in preparations for human therapeutic use for the treatment of post-traumatic stress disorder.
DIPHENOXYLATE except when included in Schedule 3 or 4.
DIPIPANONE.
# DRONABINOL (delta‑9‑tetrahydrocannabinol) when prepared and packed for therapeutic use.
DROTEBANOL.
ESKETAMINE.
ETHYLAMFETAMINE.
ETHYLMORPHINE except when included in Schedule 4.
FENTANYL.
# FLUNITRAZEPAM.
HYDROCODONE.
HYDROMORPHINOL.
HYDROMORPHONE.
KETAMINE.
LEVAMFETAMINE.
LEVOMETHAMFETAMINE.
LEVOMORAMIDE.
LEVORPHANOL (excluding its stereoisomers).
LISDEXAMFETAMINE.
METHADONE.
METAMFETAMINE.
METHYLDIHYDROMORPHINE.
METHYLPHENIDATE.
1‑METHYL‑4‑PHENYLPIPERIDINE‑4‑CARBOXYLIC ACID (Pethidine intermediate C).
MORPHINE.
MORPHINE METHOBROMIDE.
MORPHINE‑N‑OXIDE.
NABILONE.
# NABIXIMOLS (botanical extract of Cannabis sativa which includes the following cannabinoids: tetrahydrocannabinols, cannabidiol, cannabinol, cannabigerol, cannabichromene, cannabidiolic acid, tetrahydrocannabinolic acids, tetrahydrocannabivarol, and cannabidivarol, where tetrahydrocannabinols and cannabidiol (in approximately equal proportions) comprise not less than 90% of the total cannabinoid content) in a buccal spray for human therapeutic use.
NORCODEINE.
NORMETHADONE.
OPIUM except the alkaloids noscapine in Schedule 2 and papaverine when included in Schedule 2 or 4.
OXYCODONE.
OXYMORPHONE.
PENTAZOCINE.
# PENTOBARBITAL except when included in Schedule 4.
PETHIDINE.
PHENDIMETRAZINE.
PHENMETRAZINE.
PHENOPERIDINE.
4‑PHENYLPIPERIDINE‑4‑CARBOXYLIC ACID ETHYL ESTER (Pethidine intermediate B).
PHOLCODINE except when included in Schedule 2 or 4.
PIRITRAMIDE.
PROPIRAM.
# PSILOCYBINE in